References
- 1. Abe M., Syuto T., Yokoyama Y., Ishikawa O.: Aplasia cutis congenita after methimazole exposure in utero successfully treated with basic fibroblast growth factor. Intern J Dermatol 2010, 49, 334-335.
- 2. Balazs C., Kiss E., Leovey A., Farid NR.: The immunosuppressive effect of methimazole on cell-mediated immunity is mediated by its capacity to inhibit peroxidase and to scavenge free oxygen radicals. Clin Endocrinol 1986, 25, 7-16.
- 3. Bhargava H.N., Ramarao P., Gulati A.: Effect of methimazoleinduced hypothyroidism on multiple opioid receptors in rat brain regions. Pharmacology 1988, 37, 356-364.
- 4. Bourdeau P., Taylor K.W., Nguyen P., Biourge V.: Evaluation of the influence of sex, diet and time on skin pH and surface lipids of cats. Vet Dermatol 2004, 15, 41-69.
- 5. Cooper D.S.: Antithyroid drugs for the treatment of hyperthyroidism caused by Graves’ disease. Endocrinol Metab Clin North Am 1998, 27, 225-247.
- 6. Dirschka T., Tronnier H., Fo R., Holst L.: Clinical and laboratory investigations of epithelial barrier function and atopic diathesis in rosacea and perioral dermatitis. Br J Dermatol 2004, 150, 1136 -1141.
- 7. Eberlein-König B., Schaffer T., Huss-Marp J., Darsow U., Möhrenschlager M., Herbert O., Abeck D., Krämer U., Behrendt H., Ring J.: Skin surface pH, stratum corneum hydration, trans-epidermal water loss and skin roughness related to atopic eczema and skin dryness in a population of primary school children: clinical report. Acta Derm Venereol 2000, 80, 188-191.
- 8. Elias A.N., Barr R.J., Nanda V.S.: p16 expression in psoriatic lesions following therapy with propylthiouracil, an antithyroid thioureylene. Int J Dermatol 2004, 43, 889-892.
- 9. Elias A.N.: Anti-thyroid thioureylenes in the treatment of psoriasis. Med Hypotheses 2004, 62, 431-437.
- 10. Fluhr J.W., Feingold K.R., Elias P.M.: Transepidermal water loss reflects permeability barrier status: validation in human and rodent in vivo and ex vivo models. Exp Dermatol 2006, 15, 483-492.
- 11. Gołyński M., Lutnicki K.: Influence of β-endorphin on oxygen activity of neutrophils and total antioxidant status in rats after chronic administration of methimazole. Bull Vet Inst Pulawy, 2013, 57, 97-101.
- 12. Gupta J., Grube E., Ericksen M.B., Stevenson M.D., Lucky A.W., Sheth A.P., Assa’ad A.H., Khurana Hershey G.K.: Intrinsically defective skin barrier function in children with atopic dermatitis correlates with disease severity. J Allergy Clin Immunol 2008, 121, 725-730.
- 13. Hanley K., Rassner U., Jiang Y., Vansomphone D., Crumrine D., Komüves L., Elias P.M., Feingold K.R., Williams M.L.: Hormonal basis for the gender difference in epidermal barrier formation in the fetal rat. J Clin Invest. 1996, 97, 2576-2584.
- 14. Hightower K., Marsella R., Flynn-Lurie A.: Effects of age and allergen exposure on transepidermal water loss in house dust mite-sensitized beagle model of atopic dermatitis. Vet Dermatol 2010, 21, 89-96.
- 15. Hill K.E., Gieseg M.A., Kingsbury D., Lopez-Villalobos N., Bridges J., Chambers P.: The efficacy and safety of a novel lipophilic formulation of methimazole for the once daily transdermal treatment of cats with hyperthyroidism. J Vet Intern Med 2011, 25, 1357-1365.
- 16. Trepanier L.A.: Pharmacologic management of feline hyperthyroidism. Vet Clin North Am Small Anim Pract 2007, 37, 775-788.
- 17. Kasraee B., Handjani F., Parhizgar A., Omrani G.R., Fallahi M.R., Amini M., Nikbakhsh M., Tran C., Hügin A., Sorg O., Saurat J.H.: Topical methimazole as a new treatment for postinflammatory hyperpigmentation: report of the first case. Dermatology 2005, 211, 360-362.
- 18. Kasraee B., Hügin A., Tran C., Sorg O., Saurat J.H.: Methimazole is an inhibitor of melanin synthesis in cultured B16 melanocytes. J Invest Dermatol 2004, 122, 1338-1341.
- 19. Kasraee B.: Depigmentation of brown guinea pig skin by topical application of methimazole. J Invest Dermatol 2002, 118, 205-207.
- 20. Laudańska H., Reduta T., Szmitkowska D.: Evaluation of skin barrier function in allergic contact dermatitis and atopic dermatitis using method of the continuous TEWL measurement. Ann Acad Med Bialost 2003, 48, 124-127.
- 21. Lécuyer M., Prini S., Dunn M.E., Doucet M.Y.: Clinical efficacy and safety of transdermal methimazole in the treatment of feline hyperthyroidism. Can Vet J 2006, 47, 131-135.
- 22. Marrakchi S., Maibach H.I.: Biophysical parameters of skin: map of human face, regional, and age-related differences. Contact Derm 2007, 57, 28-34.
- 23. Marsella R., Olivry T., Carlotti D.N.: Current evidence of skin barrier dysfunction in human and canine atopic dermatitis. Vet Dermatol 2011, 22, 239-248.
- 24. Martin-Denavit T., Edery P., Plauchu H., Attia-Sobol J., Raudrant D., Aurand J.M., Thomas L.: Ectodermal abnormalities associated with methimazole intrauterine exposure. Am J Med Genet 2000, 94, 338-340.
- 25. Matousek J., Campbell K.L.A.: Comparative review of cutaneous pH. Vet Dermatol 2002, 13, 293-300.
- 26. Oestmann E., Lavrijsen A.P.M., Hermans J., Ponec M.: Skin barrier function in healthy volunteers as assessed by transepidermal water loss and vascular response to hexyl nicotinate: intra- and interindividual variability. Br J Dermatol 1993, 128, 130-136.
- 27. Oh W.S., Oh T.H.: Measurement of transepidermal water loss from clipped and unclipped anatomical sites on the dog. Aust Vet J 2009, 87, 409-412.
- 28. Peterson M.E., Aucoin D.P.: Comparison of the disposition of carbimazole and methimazole in clinically normal cats. Res Vet Sci 1993, 54, 351-355.
- 29. Peterson M.E., Kintzer P.P., Hurvitz A.I.: Methimazole treatment of 262 cats with hyperthyroidism. J Vet Intern Med 1988, 2, 150-157.
- 30. Popiel J., Nicpoń J.: The relationship between skin pH in the course of pyoderma in dogs before and after the applied active externally preparations. Acta Sci Pol Med Vet 2004, 3, 53-60.
- 31. Regelmann M.O., Miloh T., Arnon R., Morotti R., Kerkar N., Rapaport R.: Graves disease presenting with severe cholestasis. Thyroid 2012, 22, 437-439.
- 32. Rodríguez-García C., González-Hernández S., Hernández- Martín A., Pérez-Robayna N., Sánchez R., Torrelo A.: Aplasia cutis congenita and other anomalies associated with methimazole exposure during pregnancy. Ped Dermatol 2011, 28, 743-745.
- 33. Rudolph R., Kownatzki E.: Corneometric, sebumetric and TEWL measurements following the cleaning of atopic skin with a urea emulsion versus a detergent cleanser. Contact Derm 2004, 50, 354-358.
- 34. Schmid-Wendtner M.H., Korting H.C.: The pH of the skin surface and its impact on the barrier function. Skin Pharmacol Physiol 2006, 19, 296-302.
- 35. Scott R.C., Oliver G.J.A., Dugard P.H., Singh H.J.: A comparison of techniques for the measurement of transepidermal water loss. Arch Dermatol Res 1982, 274, 57-64.
- 36. Shimada K., Yoshihara T., Konno K., Nishifuji K.: Increase in transepidermal water loss and decrease in ceramide content in the lesional and non-lesional skin of canine atopic dermatitis. Vet Dermatol 2009, 20, 541-546.
- 37. Szczepanik M.P., Wilkołek P.M., Adamek Ł.R., Pomorski Z.: The examination of biophysical parameters of skin (transepidermal water loss, skin hydration and pH value) in different body regions of normal cats of both sexes. J Feline Med Surg 2011, 13, 224-230.
- 38. Tsujio M., Yoshioka K., Satoh M., Watahiki Y., Mutoh K.: Skin morphology of thyroidectomized rats. Vet Pathol 2008, 45, 505-511.
- 39. Vail D.M., Elfarra A.A., Panciera D.L., Hutson P.R.: Pharmacokinetics and short-term clinicopathologic changes after intravenous administration of a high dose of methimazole in dogs. Am J Vet Res 1994, 55, 1597-1601.
- 40. Wiig H., Lund T.: Relationship between interstitial fluid volume and pressure (compliance) in hypothyroid rats. Am J Physiol Heart Circ Physiol 2001, 281, 1085-1092.
- 41. Wiig H., Reed R.K., Tenstad O.: Interstitial fluid pressure, composition of interstitium, and interstitial exclusion of albumin in hypothyroid rats. Am J Physiol Heart Circ Physiol 2000, 278, 1627-1639.
- 42. Wiik A.: Clinical and laboratory characteristics of drug-induced vasculitic syndromes. Arthritis Res Ther 2005, 7, 191-192.